{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:49:35Z","timestamp":1788378575040,"version":"build-2803163510"},"reference-count":8,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.rmr.2022.09.005","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T08:25:31Z","timestamp":1666167931000},"page":"801-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pr\u00e9sentation endobronchique d\u2019une tumeur myofibroblastique inflammatoire"],"prefix":"10.1016","volume":"39","author":[{"given":"T.","family":"Clemens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ninane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fremault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2022.09.005_bib0045","unstructured":"Inflammatory Myofibroblastic Tumor (IMT). (2019, February 27). National Cancer Institute. Retrieved January 12, 2022, from https:\/\/www.cancer.gov\/pediatric-adult-rare-tumor\/rare-tumors\/rare-soft-tissue-tumors\/inflammatory-myofibroblastic-tumor."},{"key":"10.1016\/j.rmr.2022.09.005_bib0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12032-018-1161-0","article-title":"Clinical and histopathologic correlates and management strategies for inflammatory myofibroblastic tumor of the lung. A case series and review of the literature","volume":"35","author":"Sagar","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.rmr.2022.09.005_bib0055","first-page":"499","article-title":"Pseudo-tumeur inflammatoire pulmonaire compliquant l\u2019\u00e9volution d\u2019une pneumopathie communautaire. Une pr\u00e9sentation radio-clinique trompeuse","volume":"14","author":"Devouassoux","year":"1997","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2022.09.005_bib0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0300-2896(15)31150-9","article-title":"Seudotumor inflamatorio endobronquial. Presentaci\u00f3n de un caso y revisi\u00f3n de la literatura. [Endobronchial inflammatory pseudotumor. A case report and review of the literature]","volume":"30","author":"Oteo Dom\u00ednguez","year":"1994","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.rmr.2022.09.005_bib0065","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/j.athoracsur.2020.05.092","article-title":"Bronchoscopic Treatment of Endobronchial Inflammatory Myofibroblastic Tumors","volume":"111","author":"H\u00e9luain","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.rmr.2022.09.005_bib0070","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0022-5223(19)34664-1","article-title":"Plasma cell granuloma of the lung","volume":"104","author":"Urschel","year":"1992","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.rmr.2022.09.005_bib0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00007611-198704000-00028","article-title":"Recurrence\u201d of a plasma cell granuloma 11\u00a0years after initial resection","volume":"80","author":"Weinberg","year":"1987","journal-title":"South Med J"},{"key":"10.1016\/j.rmr.2022.09.005_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26920","article-title":"Crizotinib in ALK+ inflammatory myofibroblastic tumors - current experience and future perspectives","volume":"65","author":"Theilen","year":"2018","journal-title":"Pediatr Blood Cancer"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842522003114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842522003114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:24:42Z","timestamp":1760106282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842522003114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0761842522003114"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2022.09.005","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pr\u00e9sentation endobronchique d\u2019une tumeur myofibroblastique inflammatoire","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2022.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}